Revenue (Tables)

6 Months Ended

Jun. 27, 2025

Revenue from Contract with Customer [Abstract]

The following tables present the Company’s revenues disaggregated by geographical region and revenue type for the three and six-month periods ended June 27, 2025 and June 28, 2024 ($ in millions). Sales taxes and other usage-based taxes collected from customers are excluded from revenue.


	Biotechnology		Life Sciences		Diagnostics		Total
For the Three-Month Period Ended June 27, 2025:
Geographical region:
North America(a)	$	612	$	762	$	1,064	$	2,438
Western Europe	708		394		405		1,507
Other developed markets(b)	82		118		94		294
High-growth markets(c)	448		503		746		1,697
Total	$	1,850	$	1,777	$	2,309	$	5,936

Revenue type:
Recurring	$	1,694	$	1,214	$	2,062	$	4,970
Nonrecurring	156		563		247		966
Total	$	1,850	$	1,777	$	2,309	$	5,936

For the Three-Month Period Ended June 28, 2024:
Geographical region:
North America(a)	$	607	$	785	$	1,042	$	2,434
Western Europe	567		374		380		1,321
Other developed markets(b)	81		116		95		292
High-growth markets(c)	458		495		743		1,696
Total	$	1,713	$	1,770	$	2,260	$	5,743

Revenue type:
Recurring	$	1,478	$	1,208	$	2,003	$	4,689
Nonrecurring	235		562		257		1,054
Total	$	1,713	$	1,770	$	2,260	$	5,743



	Biotechnology		Life Sciences		Diagnostics		Total
For the Six-Month Period Ended June 27, 2025:
Geographical region:
North America(a)	$	1,155	$	1,483	$	2,382	$	5,020
Western Europe	1,274		772		805		2,851
Other developed markets(b)	146		241		185		572
High-growth markets(c)	887		961		1,386		3,234
Total	$	3,462	$	3,457	$	4,758	$	11,677

Revenue type:
Recurring	$	3,151	$	2,350	$	4,285	$	9,786
Nonrecurring	311		1,107		473		1,891
Total	$	3,462	$	3,457	$	4,758	$	11,677

For the Six-Month Period Ended June 28, 2024:
Geographical region:
North America(a)	$	1,121	$	1,566	$	2,379	$	5,066
Western Europe	1,113		746		786		2,645
Other developed markets(b)	160		241		194		595
High-growth markets(c)	843		962		1,428		3,233
Total	$	3,237	$	3,515	$	4,787	$	11,539

Revenue type:
Recurring	$	2,787	$	2,400	$	4,297	$	9,484
Nonrecurring	450		1,115		490		2,055
Total	$	3,237	$	3,515	$	4,787	$	11,539

(a) The Company defines North America as the United States and Canada.

(b) The Company defines other developed markets as all the markets of the world that are not North America, Western Europe or high-growth markets.

(c) The Company defines high-growth markets as developing markets of the world experiencing accelerated growth, over extended periods, in gross domestic product and infrastructure which include Eastern Europe, the Middle East, Africa, Latin America (including Mexico) and Asia (with the exception of Japan, Australia and New Zealand). The Company defines developed markets as all markets of the world that are not high-growth markets.